- Home
- AGPU vs MBOT Comparison
AGPU vs MBOT Comparison
Compare AGPU & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGPU | MBOT |
|---|---|---|
| Founded | 2002 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 73.2M |
| IPO Year | 2008 | 2000 |
Fundamental Metrics
Financial Performance| Metric | AGPU | MBOT |
|---|---|---|
| Price | $7.74 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 218.3K | ★ 861.4K |
| Earning Date | 11-16-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,284.00 | $116,887.00 |
| Revenue This Year | $48,110.47 | N/A |
| Revenue Next Year | $614.07 | $377.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.93 |
| 52 Week High | $13.49 | $2.86 |
Technical Indicators
Market Signals| Indicator | AGPU | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 44.71 | 39.89 |
| Support Level | $7.42 | N/A |
| Resistance Level | $9.15 | $1.18 |
| Average True Range (ATR) | 0.72 | 0.08 |
| MACD | 0.13 | 0.01 |
| Stochastic Oscillator | 57.69 | 10.54 |
Price Performance
Historical ComparisonAbout AGPU Axe Compute Inc. Common Stock
Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, the company aims to provide access to bare-metal GPUs at scale for both emerging and established organizations.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.